Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,550Revenue (TTM) $M2,833Net Margin (%)11.7Altman Z-Score1.4
Enterprise Value $M13,347EPS (TTM) $1.2Operating Margin %19.4Piotroski F-Score8
P/E(ttm)32.7Beneish M-Score-2.8Pre-tax Margin (%)14.7Higher ROA y-yY
Price/Book4.910-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %--Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow15.8y-y EBITDA Growth Rate %19.9ROA % (ttm)4.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)15.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M278ROIC % (ttm)8.6Gross Margin Increase y-yY

Gurus Latest Trades with HOLX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HOLXKahn Brothers 2016-09-30 Reduce-0.28%$34.44 - $39.03
($37.75)
$ 37.920%Reduce -3.33%1,234,514
HOLXLeon Cooperman 2016-09-30 Sold Out -0.1%$34.44 - $39.03
($37.75)
$ 37.920%Sold Out0
HOLXJoel Greenblatt 2016-09-30 Add0.03%$34.44 - $39.03
($37.75)
$ 37.920%Add 226.36%103,903
HOLXVanguard Health Care Fund 2016-09-30 Reduce-0.03%$34.44 - $39.03
($37.75)
$ 37.920%Reduce -5.62%6,896,300
HOLXGeorge Soros 2016-09-30 Buy 0.01%$34.44 - $39.03
($37.75)
$ 37.920%New holding7,236
HOLXKen Fisher 2016-09-30 Sold Out $34.44 - $39.03
($37.75)
$ 37.920%Sold Out0
HOLXRobert Olstein 2016-06-30 Buy 0.87%$32.93 - $37.83
($34.63)
$ 37.9210%New holding187,000
HOLXKahn Brothers 2016-06-30 Reduce-0.32%$32.93 - $37.83
($34.63)
$ 37.9210%Reduce -3.73%1,276,984
HOLXVanguard Health Care Fund 2016-06-30 Add0.11%$32.93 - $37.83
($34.63)
$ 37.9210%Add 25.92%7,306,800
HOLXLeon Cooperman 2016-06-30 Buy 0.1%$32.93 - $37.83
($34.63)
$ 37.9210%New holding100,000
HOLXKen Fisher 2016-06-30 Reduce$32.93 - $37.83
($34.63)
$ 37.9210%Reduce -21.04%37,600
HOLXJoel Greenblatt 2016-06-30 Add$32.93 - $37.83
($34.63)
$ 37.9210%Add 60.84%31,837
HOLXCarl Icahn 2016-03-31 Sold Out -3.7%$32.42 - $38.69
($34.9)
$ 37.929%Sold Out0
HOLXKahn Brothers 2016-03-31 Reduce-0.16%$32.42 - $38.69
($34.9)
$ 37.929%Reduce -1.76%1,326,484
HOLXJoel Greenblatt 2016-03-31 Reduce-0.15%$32.42 - $38.69
($34.9)
$ 37.929%Reduce -94.86%19,794
HOLXKen Fisher 2016-03-31 Add$32.42 - $38.69
($34.9)
$ 37.929%Add 0.04%47,620
HOLXJoel Greenblatt 2015-12-31 Reduce-0.07%$36.57 - $41.22
($38.92)
$ 37.92-3%Reduce -31.40%384,989
HOLXPrem Watsa 2015-12-31 Sold Out -0.07%$36.57 - $41.22
($38.92)
$ 37.92-3%Sold Out0
HOLXKahn Brothers 2015-12-31 Add0.06%$36.57 - $41.22
($38.92)
$ 37.92-3%Add 0.61%1,350,251
HOLXVanguard Health Care Fund 2015-12-31 Reduce-0.03%$36.57 - $41.22
($38.92)
$ 37.92-3%Reduce -5.80%5,802,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HOLX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HOLX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2016-11-21Sell3,023$38.32-1.04view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2016-11-15Sell1,211$36.553.75view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2016-11-08Sell984$38.57-1.69view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2016-11-07Sell522$38.53-1.58view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2016-10-10Sell31,470$40-5.2view
ULLIAN ELAINEDirector 2016-10-10Sell18,236$39.88-4.91view
CRAWFORD SALLYDirector 2016-07-21Sell16,071$372.49view
LEAMING NANCYDirector 2016-07-21Sell8,179$372.49view
LEAMING NANCYDirector 2016-07-11Sell6,221$36.045.22view
Levy Lawrence MDirector 2016-06-01Sell17,794$34.4110.2view

Quarterly/Annual Reports about HOLX:

News about HOLX:

Articles On GuruFocus.com
Robert Olstein's Best Performing Investments Include eBay Aug 14 2016 
Carl Icahn's Stakes with Positive Return Aug 04 2016 
Edward Owens Top 2nd Quarter Investments Aug 03 2016 
Carl Icahn's Largest Trades of the 2nd Quarter Jul 19 2016 
Carl Icahn Continues to Reduce Position in Hologic Apr 07 2016 
Investment Ideas Trading With Very Low P/S Ratio Jan 13 2016 
Carl Icahn Makes Big Transactions in 3rd Quarter Jan 03 2016 
Kahn Brothers' Largest Sales During 3rd Quarter Dec 22 2015 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Amazon Among Ken Fisher's Best Performing Stocks Oct 19 2015 

More From Other Websites
Hologic, Inc. breached its 50 day moving average in a Bearish Manner : HOLX-US : December 2, 2016 Dec 02 2016
Post Earnings Coverage as Medtronic Adjusted EPS Grows 15% Dec 01 2016
Hedge Funds Aren’t Crazy About Discovery Communications Inc. (DISCK) Anymore Nov 30 2016
HOLOGIC INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 28 2016
Cramer: These deals will happen before year-end Nov 28 2016
Is LKQ Corporation (LKQ) Right For Your Portfolio? Nov 25 2016
Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 Nov 25 2016
HOLOGIC INC Financials Nov 24 2016
ETFs with exposure to Hologic, Inc. : November 23, 2016 Nov 23 2016
Hologic, Inc. :HOLX-US: Earnings Analysis: 2016 By the Numbers : November 22, 2016 Nov 22 2016
HOLOGIC INC Files SEC form 10-K, Annual Report Nov 17 2016
Hologic Obtains European CE Mark for Aptima® Assay to Detect Herpes Simplex Virus 1 & 2 Nov 15 2016
Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System to Enhance... Nov 14 2016
Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System to Enhance... Nov 14 2016
Hologic Obtains Canadian Approval for Aptima® Hepatitis C and B Quant Assays Nov 10 2016
Hologic Obtains Canadian Approval for Aptima® Hepatitis C and B Quant Assays Nov 10 2016
HOLOGIC INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 09 2016
Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Exchange Senior... Nov 09 2016
Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Exchange Senior... Nov 09 2016
5 Healthcare Stocks Kahn Brothers Is Bullish On Nov 08 2016
Hologic, Inc. breached its 50 day moving average in a Bullish Manner : HOLX-US : November 8, 2016 Nov 08 2016
Hologic to Webcast Presentations at Upcoming Investor Conferences Nov 07 2016
Hologic to Webcast Presentations at Upcoming Investor Conferences Nov 07 2016
ETF’s with exposure to Hologic, Inc. : November 7, 2016 Nov 07 2016
11 improving health-care companies whose stocks are loved by analysts Nov 04 2016
Hologic, Inc. :HOLX-US: Earnings Analysis: Q4, 2016 By the Numbers : November 4, 2016 Nov 04 2016
Seegene and Hologic Form Worldwide Collaboration to Develop High Multiplex Molecular Diagnostic... Nov 04 2016
Hologic tops Street 4Q forecasts Nov 02 2016
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 Nov 02 2016
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are... Oct 03 2016
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2016 on Wednesday, November... Oct 03 2016
Hologic’s ThinPrep® Selected as Exclusive Pap Test for Netherlands Cervical Cancer Screening... Oct 02 2016
FDA Expands Emergency Use Authorization for Hologic's Aptima® Zika Virus Assay to Include Use with... Sep 08 2016
Hologic Applauds Cigna as First National Insurer to Cover Breast Tomosynthesis for Routine Breast... Aug 24 2016
Peer-Reviewed Study Concludes Hologic’s C-View™ Software Maintains Clinical Performance of... Aug 17 2016
European Study Results Published in Lancet Oncology Conclude that Low Dose 3D MAMMOGRAPHY™ Exams... Aug 09 2016
Hologic to Webcast Presentations at Upcoming Investor Conferences Aug 02 2016
National Comprehensive Cancer Network (NCCN) Includes Breast Tomosynthesis in Breast Cancer... Aug 01 2016
Hologic tops Street 3Q forecasts Jul 27 2016
Hologic Announces Financial Results for Third Quarter of Fiscal 2016 Jul 27 2016
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are... Jul 05 2016
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2016 on Wednesday, July 27,... Jul 01 2016
Hologic’s Affirm™ Prone Biopsy System Featured at Premier Inc. Annual Innovation Celebration Jun 22 2016
FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood... Jun 21 2016
Hologic tops Street 2Q forecasts Apr 27 2016
Hologic beats Street 4Q forecasts Nov 04 2015
Hologic shares climb on 3Q results and boost to outlook Jul 29 2015
Hologic beats Street 3Q forecasts Jul 29 2015
Hologic tops Street 2Q forecasts Apr 29 2015
Hologic beats Street 1Q forecasts Jan 28 2015
Hologic tops Street 4Q forecasts Nov 05 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)